Kamocsay Jennifer 4
4 · Akoya Biosciences, Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Kamocsay Jennifer
Chief Legal Officer
Transactions
- Award
Common Stock
2024-02-22+35,000→ 102,500 total - Tax Payment
Common Stock
2024-03-01$6.03/sh−3,283$19,796→ 99,217 total - Award
Employee Stock Option (Right to Buy)
2024-02-22+70,000→ 70,000 totalExercise: $5.35Exp: 2034-02-22→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on March 1, 2025, and annually thereafter until fully vested.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
- [F3]Represents shares withheld to cover taxes on a restricted stock unit award previously granted February 23, 2023, which vest in four (4) equal annual installments beginning on March 1, 2024, and annually thereafter until fully vested.
- [F4]The options shall vest as follows: twenty-five percent (25%) shall vest on February 22, 2025 with the remainder vesting in 36 equal monthly installments beginning on March 22, 2025.